• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

June 2, 2016

Trending News Today: More Insurers Proposing ACA Premium Hikes

Author(s):

Laurie Toich, Assistant Editor

Top news of the day from across the healthcare landscape.

Many large health insurers are proposing increasingly large premium hikes in the Affordable Care Act’s health exchanges. According to The New York Times, the largest insurer in Texas is proposing an increase of 60%, while North Carolina’s largest insurer is proposing an increase of 18.8%. Most insurers seeking such high premiums is due to financial losses from low enrollment rates, sicker beneficiaries, and problems with the government’s financial support, according to the report.

The use of osteoporosis medications dropped 50% from 2008 and 2012 and The New York Times reports that this decrease in use is continuing due to the chance of rare side effects from the drugs. The risk of a broken thighbone from the medication is approximately 10 to 40 in 100,000 patients and the risk of a rotting jawbone is less than 1 in 100,000. However, patients are hesitant to start the medication and if they have, a vast majority of them wish to come off of it.

A new bill that would require drugmakers to provide 60-days notice if they are going to increase the cost of a drug over 10% was approved in California. The bill would also require the companies to provide additional notice if the cost of a new drug will cost $10,000 or more annually or over the course of treatment, according to the Los Angeles Times. The hope is that this bill will provide further transparency in healthcare costs.

Related Videos
Physician discussing bone health with a patient
Related Content
Advertisement
Image Credit: © Postmodern Studio - stock.adobe.com
Published: March 4th 2025 | Updated: March 4th 2025

FDA Approves Biosimilars Referencing Denosumab for Osteoporosis-, Cancer-Related Skeletal Events

Luke Halpern, Assistant Editor
Amgen Prolia Denosumab for injection in pre-filled syringe with protective cap. Monoclonal antibody used to treat bone loss in women post menopause
February 17th 2025

FDA Approves Biosimilar Denosumab-dssb to Treat Osteoporosis-, Cancer-Related Bone Loss

Luke Halpern, Assistant Editor
Coronavirus molecules.
January 29th 2025

Common Osteoporosis Treatments May Offer Protection Against COVID-19

Luke Halpern, Assistant Editor
Osteoporosis, Biosimilar, Denosumab | Image Credit: © eddows | stock.adobe.com
December 2nd 2024

Data Further Confirm Proposed Denosumab Biosimilar Shows Similar Efficacy to Originator

Ashley Gallagher, Editor
Man suffering from knee pain sitting on sofa.
September 16th 2024

FDA Grants MM-II Fast Track Designation for Treatment of Osteoarthritis Knee Pain

Luke Halpern, Assistant Editor
Osteoporosis stage 4 of 4 in upper limb bone.
August 21st 2024

Intravenous Immunoglobulin Shows Beneficial Effects In Post-Menopausal Osteoporosis, Indicating Potential as Treatment

Sandra J. Grillo, MBA, RPh
Related Content
Advertisement
Image Credit: © Postmodern Studio - stock.adobe.com
Published: March 4th 2025 | Updated: March 4th 2025

FDA Approves Biosimilars Referencing Denosumab for Osteoporosis-, Cancer-Related Skeletal Events

Luke Halpern, Assistant Editor
Amgen Prolia Denosumab for injection in pre-filled syringe with protective cap. Monoclonal antibody used to treat bone loss in women post menopause
February 17th 2025

FDA Approves Biosimilar Denosumab-dssb to Treat Osteoporosis-, Cancer-Related Bone Loss

Luke Halpern, Assistant Editor
Coronavirus molecules.
January 29th 2025

Common Osteoporosis Treatments May Offer Protection Against COVID-19

Luke Halpern, Assistant Editor
Osteoporosis, Biosimilar, Denosumab | Image Credit: © eddows | stock.adobe.com
December 2nd 2024

Data Further Confirm Proposed Denosumab Biosimilar Shows Similar Efficacy to Originator

Ashley Gallagher, Editor
Man suffering from knee pain sitting on sofa.
September 16th 2024

FDA Grants MM-II Fast Track Designation for Treatment of Osteoarthritis Knee Pain

Luke Halpern, Assistant Editor
Osteoporosis stage 4 of 4 in upper limb bone.
August 21st 2024

Intravenous Immunoglobulin Shows Beneficial Effects In Post-Menopausal Osteoporosis, Indicating Potential as Treatment

Sandra J. Grillo, MBA, RPh
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.